ZNF-Mediated Resistance to Imatinib Mesylate in Gastrointestinal Stromal Tumor

• Lori Rink ,

  Contributed equally to this work with: Lori Rink, Michael F. Ochs

  * E-mail: Lori.Rink@fccc.edu

  Affiliation Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States of America

  ⨯
• Michael F. Ochs ,

  Contributed equally to this work with: Lori Rink, Michael F. Ochs

  Affiliation Departments of Oncology and Health Science Informatics, School of Medicine, Johns Hopkins University, Baltimore, Maryland, United States of America

  ⨯
• Yan Zhou,

  Affiliation Department of Statistics, Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States of America

  ⨯
• Margaret von Mehren,

  Affiliation Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States of America

  ⨯
• Andrew K. Godwin

  Affiliations Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, Kansas, United States of America, The University of Kansas Cancer Center, University of Kansas Medical Center, Kansas City, Kansas, United States of America

  ⨯